SCHEMBL699031

SCHEMBL699031

CCCCCCCCCCCCc1cnc(C(N)=O)c(C(N)=O)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.42
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
MAPT P10636 2/20 0.40
NR1I2 O75469 1/20 0.40
LMNA P02545 1/20 0.40
CHRM2 P08172 1/20 0.40
CYP3A4 P08684 1/20 0.40
ADRA2A P08913 1/20 0.40
OPRK1 P41145 1/20 0.40
HTR2B P41595 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
RARB P10826 1/20 0.38
PPARA Q07869 1/20 0.37
IKBKB O14920 1/20 0.36
APAF1 O14727 1/20 0.36
RGS12 O14924 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27917305 0.89 KCNH2 (0.41) KCNH2MEN1KMT2AMAPTNR1I2
SCHEMBL368929 0.88 KCNH2 (0.39) KCNH2MEN1KMT2AMAPTNR1I2
SCHEMBL9589800 0.81 IKBKB (0.39) KCNH2MEN1KMT2AMAPTNR1I2
SCHEMBL1512779 0.77 GABRP (0.41) KCNH2MEN1KMT2AMAPTLMNA
SCHEMBL13281601 0.75 KCNH2 (0.46) KCNH2MEN1KMT2AMAPTPPARA
SCHEMBL9590930 0.73 GABRP (0.43) MEN1KMT2AMAPTLMNACYP3A4
SCHEMBL3614621 0.72 KDM4E (0.41) MEN1KMT2AMAPTNR1I2LMNA
SCHEMBL3924183 0.72 KDM4E (0.41) MEN1KMT2AMAPTNR1I2LMNA
SCHEMBL3860802 0.72 GABRP (0.46) MEN1KMT2AMAPTLMNACYP3A4
SCHEMBL28647312 0.72 MAPT (0.43) MEN1KMT2AMAPTNR1I2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423215-A1 PRODRUGS BASED ON GEMCITABINE STRUCTURE AS WELL AS SYNTHETIC METHOD AND APPLICATION THEREOF Sanlugen Pharmatech Ltd. (CN) 2012-02-29 EP disclosed